Skip to main content
Article
747 The Durability of Endoscopic Therapy for Treatment of Barrett's Metaplasia, Dysplasia and Mucosal Cancer After Nissen Fundoplication
Gastroenterology (2014)
  • Corey Johnson, Division of Thoracic Surgery, Swedish Cancer Institute and Medical Center, Seattle, USA
  • Brian E. Louie, Division of Thoracic Surgery, Swedish Cancer Institute and Medical Center, Seattle, USA
  • Christy M. Dunst, The Oregon Clinic, Portland, USA
  • Steven R. DeMeester, University of Southern California
  • Michal J. Lada, University of Rochester
  • Jeffrey H. Peters, University of Rochester
  • Ralph W. Aye, Division of Thoracic Surgery, Swedish Cancer Institute and Medical Center, Seattle, USA
  • Alexander S. Farivar, Division of Thoracic Surgery, Swedish Cancer Institute and Medical Center, Seattle, USA
  • Joe Dixon, University of Southern California
  • Stephanie G. Worrell, University of Southern California
  • Jessica Reynolds, University of Southern California
  • Aaron Willie, University of Rochester
  • John Lipham, University of Southern California
Publication Date
May 1, 2014
DOI
10.1016/S0016-5085(14)63743-4
Citation Information
Corey Johnson, Brian E. Louie, Christy M. Dunst, Steven R. DeMeester, et al.. "747 The Durability of Endoscopic Therapy for Treatment of Barrett's Metaplasia, Dysplasia and Mucosal Cancer After Nissen Fundoplication" Gastroenterology Vol. 146 Iss. 5 (2014)
Available at: http://works.bepress.com/brian-louie/141/